Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma

Our pathological study of a case of poorly differentiated lymphocyte‐rich hepatocellular carcinoma suggested that immune checkpoint inhibitor may be an effective therapy. The histological type is an important factor in determining treatment choices.

Detalles Bibliográficos
Autores principales: Omori, Ginji, Osuga, Takahiro, Miyanishi, Koji, Hamaguchi, Kota, Tanaka, Shingo, Ohnuma, Hiroyuki, Murase, Kazuyuki, Takada, Kohichi, Nagayama, Minoru, Kimura, Yasutoshi, Takemasa, Ichiro, Kikuchi, Yasuhiro, Torigoe, Toshihiko, Kato, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428809/
https://www.ncbi.nlm.nih.gov/pubmed/34522383
http://dx.doi.org/10.1002/ccr3.4764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428809/
https://www.ncbi.nlm.nih.gov/pubmed/34522383
http://dx.doi.org/10.1002/ccr3.4764

Ejemplares similares